Tine Ysenbaert

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Immunization with N2 neuraminidase can protect mice against a heterologous influenza A virus challenge even in the absence of cross-NA inhibiting antibodies.

Immunization with N2 neuraminidase can protect mice against a heterologous influenza A virus challenge even in the absence of cross-NA inhibiting antibodies.

Journal: mSphere

Published: June 15, 2026

Internal gene segments from a mouse-adapted influenza B virus confer increased pathogenicity to mice.

Internal gene segments from a mouse-adapted influenza B virus confer increased pathogenicity to mice.

Journal: PloS one

Published: October 16, 2025

Immunogenicity and protection of octavalent influenza vaccine candidates using adjuvanted proteins or mRNA-LNPs in naïve mice.

Immunogenicity and protection of octavalent influenza vaccine candidates using adjuvanted proteins or mRNA-LNPs in naïve mice.

Journal: NPJ vaccines

Published: September 16, 2025

The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.

The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.

Journal: eLife

Published: May 28, 2024

Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza B.

Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza B.

Journal: PloS one

Published: August 29, 2022

Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells.

Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells.

Journal: PloS one

Published: October 14, 2021

Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase.

Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase.

Journal: NPJ vaccines

Published: September 10, 2021

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies.

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies.

Journal: Cell death & disease

Published: September 06, 2021

Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies.

Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies.

Journal: mBio

Published: October 24, 2019

Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice.

Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice.

Journal: Journal of translational medicine

Published: March 19, 2019

Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs.

Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs.

Journal: NPJ vaccines

Published: April 06, 2018

Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.

Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.

Journal: Journal of virology

Published: September 07, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026